Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC EGFR T790M/L858R-IN-2 | 2955607-40-4 | 99.7% | 497.57 | 100 MG
SDP

Catalog No. 5000361794
Encompass_Preferred

EGFR T790M/L858R-IN-2 is a potent and selective inhibitor of EGFRT790M/L858R and EGFR WT. It decreases the expression of p-EGFR, P-AKT, and P-ERK1/2, and induces apoptosis and cell cycle arrest in the G1 phase, demonstrating anti-cancer activity.

  • Potent and selective EGFRT790M/L858R inhibitor
  • Decreases expression of p-EGFR, P-AKT, and P-ERK1/2
  • Induces apoptosis
  • Induces cell cycle arrest in the G1 phase
  • Shows anti-cancer activity
  • For research use only

Catalog No. 50-003-61794 Supplier Medchemexpress LLC Supplier No. HY149824100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

EGFR T790M/L858R-IN-2 is a potent and selective inhibitor of EGFRT790M/L858R and EGFR WT. It decreases the expression of p-EGFR, P-AKT, and P-ERK1/2, and induces apoptosis and cell cycle arrest in the G1 phase, demonstrating anti-cancer activity.

  • Potent and selective EGFRT790M/L858R inhibitor
  • Decreases expression of p-EGFR, P-AKT, and P-ERK1/2
  • Induces apoptosis
  • Induces cell cycle arrest in the G1 phase
  • Shows anti-cancer activity
  • For research use only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.